Autonomous Technologies Holding PRK Laser Shipments Until Summit Merger
This article was originally published in The Gray Sheet
Executive Summary
Shipments of LADARVision tracker-assisted excimer laser systems for photorefractive keratectomy are being held until completion of Autonomous Technologies' previously planned merger with PRK laser firm Summit Technology on account of patent litigation concerns, Autonomous says. The October deal is anticipated to close in January.
You may also be interested in...
LADARVision Gets Panel Nod For LASIK Hyperopia Correction With Conditions
Laser-assisted in situ keratomileusis (LASIK) labeling for Autonomous Technologies Corp.' s LADARVision ophthalmic excimer laser system should highlight declining predictability of outcome in patients with a pre-operative manifest refractive spherical equivalance (MRSE) or uncorrected visual acuity (UCVA) greater than +/-4 diopters.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”